bf/NASDAQ:ZYXI_icon.jpeg

COM:ZYNEX

Zynex Medical

  • Stock

Last Close

8.11

22/11 21:00

Market Cap

263.04M

Beta: -

Volume Today

63.59K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
5.58M
-
3.47M
37.85%
1.12M
67.71%
206K
81.61%
265K
28.64%
630K
137.74%
1.61M
155.16%
5.51M
242.55%
9.70M
76.07%
12.12M
25.01%
average payables
2.40M
-
2.64M
10.15%
2.51M
5.03%
2.68M
6.67%
2.56M
4.37%
1.90M
25.91%
1.84M
2.90%
3.42M
85.89%
4.73M
38.04%
5.17M
9.35%
average receivables
10.07M
-
5.69M
43.51%
2.94M
48.32%
2.73M
7.29%
2.61M
4.42%
2.49M
4.55%
4.31M
73.31%
9.84M
128.08%
21.23M
115.91%
31.85M
49.98%
book value per share
0.14
-
-0.03
124.56%
-0.12
230.88%
-0.11
6.75%
0.14
230.72%
0.26
86.07%
0.55
110.73%
1.53
175.83%
1.93
26.42%
1.73
10.59%
capex per share
-0.02
-
-0.01
57.84%
-0.00
-
-0.03
1,130.40%
-0.00
85.18%
-0.03
489.63%
-0.02
39.88%
-0.01
31.63%
-0.03
207.08%
capex to depreciation
-0.77
-
-0.41
46.31%
-0.30
-
-2.42
693.96%
-0.21
91.48%
-0.63
204.68%
-0.27
57.48%
-0.13
49.82%
-0.45
236.14%
capex to operating cash flow
1.69
-
-0.28
116.79%
-0.01
-
-0.12
991.92%
-0.03
77.93%
-1.20
4,643.62%
-0.09
92.72%
-0.03
65.30%
-0.07
123.36%
capex to revenue
-0.03
-
-0.02
17.62%
-0.00
-
-0.03
813.05%
-0.00
89.62%
-0.01
249.39%
-0.00
61.98%
-0.00
43.46%
-0.01
147.58%
cash per share
0.01
-
0.00
80.53%
0.00
87.33%
0.01
2,987.52%
0.16
2,091.03%
0.28
80.05%
0.39
38.90%
1.05
167.23%
1.11
5.77%
0.52
52.91%
days of inventory on hand
224.29
-
92.78
58.63%
22.55
75.70%
11.10
50.75%
32.04
188.52%
50.60
57.92%
98.48
94.63%
180.96
83.76%
143.70
20.59%
153.78
7.02%
days payables outstanding
123.00
-
121.99
0.82%
183.13
50.12%
298.79
63.16%
169.89
43.14%
93.82
44.78%
88.33
5.85%
98.85
11.91%
63.31
35.95%
63.88
0.89%
days sales outstanding
133.42
-
113.50
14.93%
76.07
32.98%
83.02
9.14%
34.04
59.00%
31.92
6.22%
46.82
46.69%
63.04
34.63%
80.20
27.24%
80.91
0.89%
debt to assets
0.35
-
0.68
92.91%
1.17
72.40%
0.74
36.84%
0.04
94.64%
0.17
-
0.10
38.67%
0.26
159.20%
0.23
12.08%
debt to equity
1.24
-
-4.02
423.95%
-1.09
72.99%
-0.81
25.03%
0.07
108.71%
0.24
-
0.13
45.64%
0.47
268.11%
0.41
14.41%
dividend yield
0.02
-
0.01
-
0.00
-
0.01
234,401.02%
0.00
99.89%
earnings yield
-0.64
-
-1.22
90.06%
-0.21
82.93%
0.01
103.58%
0.07
879.26%
0.10
38.78%
0.04
63.20%
0.02
46.47%
0.05
147.42%
0.03
35.30%
0.02
22.39%
enterprise value
17.14M
-
9.86M
42.47%
18.33M
85.90%
12.06M
34.22%
95.96M
695.70%
84.41M
12.03%
245.94M
191.34%
424.04M
72.42%
339.77M
19.87%
541.89M
59.49%
enterprise value over ebitda
-2.56
-
-1.94
24.36%
-8.88
357.90%
13.85
255.87%
10.73
22.51%
8.14
24.13%
22.22
173.02%
36.11
62.46%
15.19
57.93%
23.62
55.51%
ev to operating cash flow
-44.88
-
10.26
122.87%
53.77
423.89%
7.09
86.81%
11.62
63.76%
8.97
22.76%
39.02
334.87%
518.38
1,228.54%
48.89
90.57%
39.42
19.37%
ev to sales
0.79
-
0.89
12.22%
1.57
77.53%
0.91
42.48%
4.10
352.08%
2.64
35.42%
5.41
104.50%
5.29
2.15%
2.61
50.73%
3.43
31.39%
free cash flow per share
-0.03
-
0.02
167.03%
0.01
50.61%
0.05
398.54%
0.23
367.53%
0.23
0.78%
0.17
26.07%
-0.00
102.60%
0.17
3,791.28%
0.35
109.40%
0.46
32.16%
free cash flow yield
-0.09
-
0.14
250.32%
0.02
82.01%
0.18
652.79%
0.08
55.89%
0.09
9.01%
0.02
72.68%
-0.00
101.52%
0.02
5,083.45%
0.02
36.44%
0.04
68.81%
graham net net
-0.11
-
-0.14
31.76%
-0.17
21.39%
-0.15
8.04%
0.10
161.92%
0.16
68.00%
0.31
91.20%
1.03
236.26%
0.26
74.49%
0.08
69.72%
graham number
0.83
-
0.38
54.38%
0.47
24.52%
0.07
85.13%
0.81
1,064.86%
1.26
54.51%
1.82
44.85%
2.89
58.92%
4.40
52.21%
4.15
5.78%
income quality
0.05
-
-0.15
396.35%
-0.12
24.64%
24.64
21,298.52%
1.12
95.45%
0.98
12.18%
0.66
32.58%
0.09
86.42%
0.41
350.71%
0.81
98.45%
1.82
126.28%
intangibles to total assets
0.01
-
0.02
78.15%
0.02
8.73%
0.01
58.49%
0
100%
0
0
0
0.23
Infinity%
0.25
11.01%
0
100%
interest coverage
-12.52
-
-10.63
15.11%
-4.93
53.59%
1.82
136.86%
6.17
239.26%
67.34
991.68%
2.21K
3,186.72%
539.42
75.63%
235.43
56.35%
52.13
77.86%
-9.85
118.90%
interest debt per share
0.19
-
0.16
19.67%
0.14
10.19%
0.10
30.08%
0.05
48.05%
0.00
91.55%
0.13
2,950.16%
0.20
50.16%
0.92
365.43%
0.71
22.43%
inventory turnover
1.63
-
3.93
141.73%
16.19
311.48%
32.87
103.06%
11.39
65.34%
7.21
36.68%
3.71
48.62%
2.02
45.58%
2.54
25.93%
2.37
6.56%
invested capital
1.24
-
-4.02
423.95%
-1.09
72.99%
-0.81
25.03%
0.07
108.71%
0.24
-
0.13
45.64%
0.47
268.11%
0.41
14.41%
market cap
11.40M
-
5.09M
55.33%
14.02M
175.10%
9.28M
33.78%
101.17M
990.00%
94.54M
6.55%
255.29M
170.03%
455.88M
78.57%
347.29M
23.82%
535.08M
54.07%
393.59M
26.44%
net current asset value
1.33M
-
-2.68M
301.05%
-5.00M
86.88%
-4.47M
10.60%
4.34M
197.16%
7.44M
71.27%
13.94M
87.39%
47.70M
242.15%
23.34M
51.07%
19.45M
16.66%
net debt to ebitda
-0.86
-
-0.94
9.23%
-2.09
123.12%
3.19
252.42%
-0.58
118.27%
-0.98
67.63%
-0.85
13.42%
-2.71
220.66%
-0.34
87.59%
0.30
188.32%
net income per share
-0.21
-
-0.18
15.25%
-0.08
53.14%
0.00
102.37%
0.21
10,280.14%
0.27
28.31%
0.27
0.43%
0.24
8.44%
0.45
83.26%
0.44
0.71%
0.27
39.24%
operating cash flow per share
-0.01
-
0.03
351.12%
0.01
64.59%
0.05
398.54%
0.23
372.51%
0.26
12.68%
0.18
32.87%
0.02
87.57%
0.18
725.99%
0.36
97.04%
0.49
37.48%
payables turnover
2.97
-
2.99
0.83%
1.99
33.39%
1.22
38.71%
2.15
75.87%
3.89
81.08%
4.13
6.21%
3.69
10.64%
5.77
56.14%
5.71
0.88%
receivables turnover
2.74
-
3.22
17.54%
4.80
49.21%
4.40
8.37%
10.72
143.91%
11.44
6.64%
7.80
31.83%
5.79
25.72%
4.55
21.41%
4.51
0.88%
research and ddevelopement to revenue
return on tangible assets
-0.43
-
-0.89
107.23%
-0.80
9.47%
0.02
102.12%
0.82
4,749.82%
0.59
28.45%
0.34
43.13%
0.13
62.55%
0.17
32.21%
0.20
17.90%
revenue per share
0.63
-
0.32
48.82%
0.34
4.50%
0.39
14.36%
0.66
71.16%
0.89
34.76%
1.27
42.75%
2.15
68.76%
3.40
58.13%
4.11
20.91%
5.10
24.03%
roe
-1.50
-
5.16
445.14%
0.73
85.84%
-0.02
102.54%
1.48
8,040.74%
1.02
31.04%
0.48
52.75%
0.16
66.81%
0.23
44.96%
0.26
11.05%
roic
-0.63
-
-1.56
148.37%
-3.63
133.27%
-1.21
66.65%
1.61
232.71%
1.03
35.75%
0.30
70.74%
0.13
57.62%
0.13
4.64%
0.16
19.88%
sales general and administrative to revenue
0.25
-
0.23
10.17%
0.20
11.66%
0.23
13.00%
0.26
15.30%
shareholders equity per share
0.14
-
-0.03
124.56%
-0.12
230.88%
-0.11
6.75%
0.14
230.72%
0.26
86.07%
0.55
110.73%
1.53
175.83%
1.93
26.42%
1.73
10.59%
stock based compensation to revenue
0.01
-
0.01
36.39%
0.01
33.49%
0.02
34.52%
0.00
81.25%
0.01
311.57%
0.02
55.56%
0.03
85.56%
0.01
62.62%
0.01
18.37%
0.01
15.88%
tangible asset value
4.67M
-
-1.40M
129.94%
-4.14M
196.49%
-3.84M
7.45%
4.90M
227.79%
9.30M
89.68%
19.65M
111.37%
56.85M
189.29%
43.55M
23.40%
36.89M
15.29%
tangible book value per share
0.14
-
-0.04
129.88%
-0.12
195.89%
-0.11
7.45%
0.14
224.27%
0.26
87.65%
0.55
111.79%
1.53
177.08%
1.14
25.52%
0.96
15.62%
working capital
4.02M
-
-2.35M
158.51%
-4.77M
102.93%
-4.32M
9.43%
4.36M
200.76%
7.97M
82.99%
17.37M
117.90%
52.91M
204.60%
59.82M
13.06%
48.47M
18.97%

All numbers in (except ratios and percentages)